Ospedale Borgo Roma

The trials here

What the 5 trials at this site are about, from their registry records.

Conditions

• Childhood cancers1 trial
• High blood pressure1 trial
• Parkinson disease1 trial
• Pulmonary arterial hypertension1 trial
• Sarcoma1 trial

Phase

• Phase 1/21 trial
• Phase 21 trial

Status

• Completed3 trials
• Active, not recruiting1 trial
• Recruiting1 trial

Lead sponsor

• Bial - Portela C S.A.1 trial
• Fondazione IRCCS Istituto Nazionale dei Tumori, Milano1 trial
• Fondazione Italiana Linfomi - ETS1 trial
• Janssen Research & Development, LLC1 trial
• Janssen-Cilag S.p.A.1 trial

Running trials

• Active, not recruiting

  REal-life ON PARKinson's - ITaly (REONPARK-IT)

  NCT07403799· Bial - Portela C S.A.· Source

• Recruiting

  REtroperitoneal SArcoma Registry: an International Prospective Initiative

  NCT03838718· Fondazione IRCCS Istituto Nazionale dei Tumori, Milano· Source

  Contact: Tommaso Campagnaro, MD

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Sarcoma1 recruiting

Closed trials

• Completed

  A Study of Pulmonary Arterial Hypertension Participants Treated With Macitentan or Selexipag

  NCT04567602· Janssen-Cilag S.p.A.· Source

• Completed

  A Study of Erdafitinib in Participants With Advanced Solid Tumors and Fibroblast Growth Factor Receptor (FGFR) Gene Alterations

  NCT04083976· Phase 2· Janssen Research & Development, LLC· Source

• Completed

  Ro Plus CHOEP as First Line Treatment Before HSCT in Young Patients With Nodal Peripheral T-cell Lymphomas

  NCT02223208· Phase 1/2· Fondazione Italiana Linfomi - ETS· Source